CeriBell, Inc. (CBLL) Financial Analysis & Valuation | Quarter Chart
CeriBell, Inc. (CBLL)
CBLLPrice: $17.59
Fair Value: 🔒
🔒score
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offer... more
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detec... more
Description
Shares
| Market Cap | $652.40M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Xingjuan Chao |
| IPO Date | 2024-10-11 | CAGR | 0.51% |
| Employees | 281 | Website | ceribell.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
CBLL chart loading...
Fundamentals
Technicals
| Enterprise Value | $799.37M | P/E Ratio | -5.92 |
| Forward P/E | -21.07 | PEG Ratio | — |
| P/S Ratio | 7.33 | P/B Ratio | 3.75 |
| P/CF Ratio | -15.98 | P/FCF Ratio | -15.59 |
| EPS | $-3.67 | EPS Growth 1Y | -62.21% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 36.09% | Gross Margin | 0.88% |
| Operating Margin | -0.66% | Profit Margin | -0.6% |
| ROE | -0.31% | ROA | -0.27% |
| ROCE | -0.33% | Current Ratio | 9.73 |
| Quick Ratio | 9.35 | Cash Ratio | 2.11 |
| Debt/Equity | 0.14 | Interest Coverage | -30.9 |
| Altman Z Score | 17.39 | Piotroski Score | 1 |